fingolimod hydrochloride has been researched along with Depressive Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agashivala, N; Agius, M; Barbato, L; Chin, P; Cutter, G; Hollander, E; Hunter, SF; McCague, K; Meng, X; Miller, DM | 1 |
1 trial(s) available for fingolimod hydrochloride and Depressive Disorder
| Article | Year |
|---|---|
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Disability Evaluation; Drug Administration Routes; Drug Substitution; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult | 2016 |